Primary Record
Pranlukast
- In stock
- 5,973 g
- Purity
- 99.5 %
- CAS
- 103177-37-3
Compound Identifiers & Properties
- CAS
- 103177-37-3
- PubChem CID
- 4887
- SMILES
- C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5
- Canonical SMILES
- O=C(Nc1cccc2c(=O)cc(-c3nn[nH]n3)oc12)c1ccc(OCCCCc2ccccc2)cc1
Names & Synonyms
- Pranlukast
- Azlaire
- 103177-37-3
- pranlukast hydrate
- Onon
- Ono-1078
- null
- pranlukastum
- Pranlukast (INN)
- Ono-RS-411
- Azlaire (TN)
- ONO 1078
- Pranlukast [INN:BAN]
- Pranlukast (Standard)
- ONO-RS 411
- PRANLUKAST [MI]
- PRANLUKAST 25MG
- Pranlukast [BAN:INN]
- PRANLUKAST [INN]
- 2-Chloro-5-iodopyrazine
- RefChem:175724
- PRANLUKAST 100MG
- CCN 00401
- DTXSID3043782
- RS 411
- CHEMBL21333
- D08QIP
- AC1L1J6B
- PRANLUKAST [MART.]
- SCHEMBL3693
- C27H23N5O4
- PRANLUKAST [WHO-DD]
- RS-411
- DTXCID1023782
- UNII-TB8Z891092
- MLS006010078
- SB 205312
- UNII-FR702N558K
- CCN-00401
- NBQKINXMPLXUET-UHFFFAOYSA-N
- GTPL3634
- ONO RS-411
- orb1310378
- SCHEMBL18058592
- SCHEMBL29349894
- SCHEMBL31756724
- TB8Z891092
- CHEBI:94810
- CTK7F7297
- HY-B0290R
- KS-00000YQJ
- CID4887
- R03DC02
- MFCD00864631
- GLXC-21321
- HMS2089H16
- HMS3650A14
- HMS3714E03
- ONO-RS-411-01
- Pranlukast =98.0% (by HPLC)
- BCP04577
- CID:4887
- HY-B0290
- ZINC1542146
- SB-205312
- Tox21_112952
- AC-696
- BDBM50023198
- MFCD24539454
- MFCD25972840
- NCGC00181765-01
- AKOS015967342
- C27-H23-N5-O4
- C27H23N5O4.1/2H2O
- CCG-220661
- CS-2304
- DB01411
- FP27120
- SB19080
- N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide
- AK481332
- AN-15615
- AS-15105
- BC220515
- DA-77034
- O046
- SC-15917
- SID:53786954
- SMR004701229
- SY113837
- AB2000316
- J326.578A
- LS-194954
- LS-194966
- N-(4-OXO-2-(1H-TETRAZOL-5-YL)-4H-CHROMEN-8-YL)-4-(4-PHENYLBUTOXY)BENZAMIDE
- B2009
- CAS-103177-37-3
- FT-0652673
- NS00068609
- P2115
- A11908
- C71133
- D08408
- K-0349
- 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran
- AB01275471-01
- 177P373
- A800688
- C047681
- L013134
- SR-05000001474
- Q7238392
- SR-05000001474-1
- SR-05000001474-2
- SR-05000001474-3
- BRD-K97045029-001-01-9
- BRD-K97045029-001-02-7
- BRD-K97045029-001-04-3
- n-[4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide
- 150821-03-7
- N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide
- 8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran
- N-(4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide
- N-{4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide
- 8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran
- N-(4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl)-4-(4-phenylbutoxy)benzamide
- N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide;N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide
- 4-oxo-8-[4-(4-phenylbutoxy)benzoylamino]-2-(tetrazol-5-yl)-4h-1-benzopyran
- 8-[4-(4-phenylbutoxy)benzamido]-2-(tetrazol-5-yl)-4H-1-benzopy-ran-4-one
- 8-[4-(4-phenylbutyloxy)benzoyl]amino-2-(tetrazol-5-yl)-4-oxo-4H-1-benzopyran
- Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-
- N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide
- N-(4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide
- N-[2-(1H-Tetrazole-5-yl)-4-oxo-gamma-chromene-8-yl]-4-(4-phenylbutoxy)benzamide
- N-[4-oxo-2-(1H-1,2,3,4-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide
- N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4(4-phenylbutoxy)benzamide
- N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide
- N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide
- N-[4-Oxo-2-(1H-tetrazole-5-yl)-2-chromene-8-yl]-4-(4-phenylbutyloxy)benzamide
- N-[4-oxo-2-(2H-tetrazol-5-yl)-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide
- 808-178-9
- Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-, hydrate (2:1)
- BENZAMIDE, N-(4-OXO-2-(2H-TETRAZOL-5-YL)-4H-1-BENZOPYRAN-8-YL)-4-(4-PHENYLBUTOXY)-
- Benzamide, N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-; Benzamide, N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)- (9CI); N-[4-Oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide; 4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran; 8-[4-(4-Phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran; Azlaire; CCN 00401; ONO 1078; ONO-RS 411; Onon; Pranlukast; RS 411; SB 205312
- KNT
- N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide (ONO-RS-411)
- N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide(ONO-RS-411)